EVALUATION OF LIPID-LOWERING THERAPY IN PATIENTS WITH DEFINITE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN LODZ

被引：0
|
作者：
Gorzelak-Pabis, P. [1 ]
Pawlos, A. [2 ]
Staciwa, Z. [1 ]
Krulikowska, A. [1 ]
Broncel, M. [1 ]
机构：
[1] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, Lodz, Poland
[2] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lab Tissue Immunopharmacol, Lodz, Poland
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP409
引用
收藏
页码：E225 / E226
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
    Kastelein, John J. P.
    Robinson, Jennifer G.
    Farnier, Michel
    Krempf, Michel
    Langslet, Gisle
    Lorenzato, Christelle
    Gipe, Daniel A.
    Baccara-Dinet, Marie T.
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (03) : 281 - 289
  • [22] Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
    John J. P. Kastelein
    Jennifer G. Robinson
    Michel Farnier
    Michel Krempf
    Gisle Langslet
    Christelle Lorenzato
    Daniel A. Gipe
    Marie T. Baccara-Dinet
    Cardiovascular Drugs and Therapy, 2014, 28 : 281 - 289
  • [23] Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia
    Junior Lima Santos, Paulo Caleb
    Morgan, Aline Cruz
    Jannes, Cintia Elin
    Turolla, Luciana
    Krieger, Jose Eduardo
    Santos, Raul D.
    Pereira, Alexandre Costa
    ATHEROSCLEROSIS, 2014, 233 (01) : 206 - 210
  • [24] Low-density lipoprotein receptor negative compound heterozygous familial hypercholesterolemia: Two lifetime journeys of lipid-lowering therapy
    Yahya, Reyhana
    Mulder, Monique T.
    Sijbrands, Eric J. G.
    Williams, Monique
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (01) : 301 - 305
  • [25] Lipid-lowering effect of atorvastatin in homozygous familial hypercholesterolemia patients with portocaval anastomosis
    Gaudet, D
    Couture, P
    Tremblay, G
    Brun, D
    Perron, P
    Bergeron, J
    Gagne, C
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 124 - 124
  • [26] Attenuated response of myocardial flow reserve to lipid-lowering therapy with atorvastatin in patients with familial hypercholesterolemia.
    Ishida, Y
    Tsushima, M
    Fukuchi, K
    Miyake, Y
    Sagoh, M
    Oka, H
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 54P - 54P
  • [27] Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy
    Miname, Marcio H.
    Bittencourt, Marcio Sommer
    Moraes, Sergio R.
    Alves, Romulo I. M.
    Silva, Pamela R. S.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Krieger, Jose E.
    Nasir, Khurram
    Santos, Raul D.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (09) : 1797 - 1804
  • [28] Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
    Raal, Frederick J.
    Pilcher, Gillian J.
    Panz, Vanessa R.
    van Deventer, Hendrick E.
    Brice, Brigitte C.
    Blom, Dirk J.
    Marais, A. David
    CIRCULATION, 2011, 124 (20) : 2202 - 2207
  • [29] Familial Hypercholesterolemia in Children and Safety of Early Lipid-Lowering Treatment
    Bellunghi, Maria Sol
    Miname, Marcio
    Jannes, Cinthia E.
    Silva, Pamela R.
    Pereira, Alexandre
    Chacra, Ana Paula
    Salgado, Wilson
    Santos, Raul D.
    Rocha, Viviane Z.
    CIRCULATION, 2017, 136
  • [30] Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia
    Stuyt, PMJ
    Kleinjans, HAJ
    Stalenhoef, AFH
    NETHERLANDS JOURNAL OF MEDICINE, 1998, 53 (05): : 228 - 233
12345